The Falsified Medicines Directive
Patricia tells us how falsified medicines have existed for decades and how the pharmaceutical industry needs to do something.
Qualification Activities for the Pharmaceutical Industry
Rita, Life Sciences Consultant at ALTEN, tells us more about the Pharmaceutical Industry’s qualification activities.
Implementation of the new veterinary medicines regulation
Our Life Science Consultant expert, Vânia, tells us about the new veterinary medicines regulation and its implementation.
The EU-US Mutual Recognition Agreement for manufacturers inspection for human medicines
Sara, LS Consultant, tells us about the Mutual Recognition Agreement ( MRA ) for the manufactures inspections of human medicines.
Rare vs common Diseases: main differences in the pharmaceutical world
Sara, ALTEN’s Life Sciences and Medical Affairs Consultant, tells us about the differences that exist between rare and common diseases.
European Medicines Agency (EMA) restricts quinolones and fluoroquinolones antibiotics
María is a Life Sciences’ Consultant at ALTEN. She talks about the potential risks of using quinolones and fluoroquinolones antibiotics.
Advanced therapy medicinal products
Roman is a Medical Affairs’ and an LS consultant. He explains everything about innovative medicines and the therapy medicinal products.
Strategic projects management in the pharmaceutical industry
Milyeris, Life Sciences’ Consultant is an expert in engineering’s strategic project management in the pharmaceutical industry.
The new Sanitary Products Regulation
Our Life Sciences consultant María, from ALTEN Spain, is an expert in Quality Assurance. She talks about the new Sanitary Products Regulation.
Scientific articles
Roman, Life Sciences consultant, an expert in Medical Affairs, talks to us about scientific articles and its importance for the pharmaceutical industry.
Elemental Impurities in pharmaceutical products
Life Sciences team will attend “Farmaforum” in March in Madrid. Ana, LS consultant will be at the Pharmaceutical Forum.
